NEPHROBLASTOMA
Clinical trials for NEPHROBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new NEPHROBLASTOMA trials appear
Sign up with your email to follow new studies for NEPHROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a cancer drug that blocks a key protein help kids with relapsed wilms tumor?
Disease control Recruiting nowThis phase II trial is testing the drug selinexor in people with Wilms tumor, rhabdoid tumor, MPNST, or other solid tumors that have returned or not responded to treatment. Selinexor works by blocking a protein called XPO1, which is often overactive in these cancers. The study ai…
Matched conditions: NEPHROBLASTOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New hope for kids with tough cancers: GAIA-102 trial launches
Disease control Recruiting nowThis early-stage trial tests a new drug called GAIA-102 in children whose neuroblastoma or other solid tumors have not responded to standard treatments. The study has four groups, testing GAIA-102 alone or combined with other cancer drugs. The main goal is to check safety and fin…
Matched conditions: NEPHROBLASTOMA
Phase: PHASE1 • Sponsor: Kyushu University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Can african hospitals follow the rules for treating childhood kidney cancer?
Knowledge-focused Recruiting nowThis study looks at how well hospitals in Africa follow recommended treatment steps for children with a type of kidney cancer called nephroblastoma. Researchers will check if doctors correctly diagnose the disease, give the right treatments, and track how children recover. The go…
Matched conditions: NEPHROBLASTOMA
Sponsor: French Africa Pediatric Oncology Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC